SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-034221
Filing Date
2020-06-03
Accepted
2020-06-03 18:45:58
Documents
2
Period of Report
2020-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2232
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4003
  Complete submission text file 0001209191-20-034221.txt   7622
Mailing Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617
Business Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Issuer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address UROVANT SCIENCES LTD. 5281 CALIFORNIA AVE SUITE 100 IRVINE CA 92617
Business Address
Johnston Walt (Reporting) CIK: 0001813699 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38667 | Film No.: 20941404